Bioventus Inc.BVSNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank83
3Y CAGR-1.9%
5Y CAGR+10.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-1.9%/yr
vs +14.7%/yr prior
5Y CAGR
+10.2%/yr
Recent deceleration
Acceleration
-16.7pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$313.17M-4.3%
2024$327.09M+7.6%
2023$303.88M-8.5%
2022$332.13M+30.6%
2021$254.25M+31.7%
2020$193.08M-2.7%
2019$198.47M+3.5%
2018$191.67M+16.3%
2017$164.84M+2.8%
2016$160.32M-